Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation. Pharm Pract (Granada) [Internet]. 2020 Jun. 13 [cited 2026 Jun. 16];18(2):1936. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/1936